Trial · NCT02303392
Adverse events586
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 586
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Abdominal pain | Gastrointestinal disorders | Chronic Lymphocytic Leukemia (CLL) | 2 | 16 | 4 |
| other | Abdominal pain | Gastrointestinal disorders | Non-Hodgkin Lymphoma (NHL) | 3 | 18 | 3 |
| other | Actinic Keratosis | Skin and subcutaneous tissue disorders | Chronic Lymphocytic Leukemia (CLL) | 1 | 16 | 1 |
| other | Actinic Keratosis | Skin and subcutaneous tissue disorders | Non-Hodgkin Lymphoma (NHL) | 0 | 18 | 0 |
| other | Activated partial thromboplastin time prolonged | Investigations | Chronic Lymphocytic Leukemia (CLL) | 3 | 16 | 8 |
| other | Activated partial thromboplastin time prolonged | Investigations | Non-Hodgkin Lymphoma (NHL) | 7 | 18 | 13 |
| other | Otitis media | Infections and infestations | Chronic Lymphocytic Leukemia (CLL) | 1 | 16 | 1 |
| other | Otitis media | Infections and infestations | Non-Hodgkin Lymphoma (NHL) | 0 | 18 | 0 |
| other | Alkaline Phosphatase increased | Investigations | Chronic Lymphocytic Leukemia (CLL) | 5 | 16 | 10 |
| other | Alkaline Phosphatase increased | Investigations | Non-Hodgkin Lymphoma (NHL) | 4 | 18 | 5 |
| other | Allergic rhinitis | Respiratory, thoracic and mediastinal disorders | Chronic Lymphocytic Leukemia (CLL) | 6 | 16 | 6 |
| other | Allergic rhinitis | Respiratory, thoracic and mediastinal disorders | Non-Hodgkin Lymphoma (NHL) | 3 | 18 | 3 |
| other | Alanine aminotransferase increased | Investigations | Chronic Lymphocytic Leukemia (CLL) | 3 | 16 | 9 |
| other | Alanine aminotransferase increased | Investigations | Non-Hodgkin Lymphoma (NHL) | 1 | 18 | 1 |
| other | Altered Mental Status | Nervous system disorders | Chronic Lymphocytic Leukemia (CLL) | 1 | 16 | 1 |
| other | Altered Mental Status | Nervous system disorders | Non-Hodgkin Lymphoma (NHL) | 0 | 18 | 0 |
| other | Anemia | Blood and lymphatic system disorders | Chronic Lymphocytic Leukemia (CLL) | 14 | 16 | 39 |
| other | Anemia | Blood and lymphatic system disorders | Non-Hodgkin Lymphoma (NHL) | 14 | 18 | 48 |
| other | Anorexia | Metabolism and nutrition disorders | Chronic Lymphocytic Leukemia (CLL) | 8 | 16 | 11 |
| other | Anorexia | Metabolism and nutrition disorders | Non-Hodgkin Lymphoma (NHL) | 10 | 18 | 12 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02303392/events